Stories Related to In Quiet Debut, Alzheimer’s Drug Finds Skepticism

The first new Alzheimer’s treatment in more than 20 years was hailed as a breakthrough when regulators approved it more than four months ago, but its rollout has been slowed by questions about its price and how well it works. Several major medical centers remain undecided on whether to use Biogen’s Aduhelm, which is recommended for early stages of the disease.

Sections:  u.s.   
Topics:  Maine   Penobscot County   Bangor   
BING NEWS:
  • Breakthrough Alzheimer’s drug slows down cognitive decline in dementia patients
    Lewy body disease (LBD), which includes dementia with Lewy bodies (DLB) and Parkinson’s disease with or without dementia, is an insidious neurodegenerative disorder. It’s second only to Alzheimer’s ...
    11/17/2024 - 6:07 am | View Link
  • New drug targets for Alzheimer's identified from cerebrospinal fluid
    Researchers have linked disease-related proteins and genes to identify specific cellular pathways responsible for Alzheimer's genesis and progression. The proteins were gathered from cerebrospinal ...
    11/15/2024 - 10:03 am | View Link
  • European regulators green light new Alzheimer's drug after first rejecting it
    European regulators initially said in July that the drug's benefits did not outweigh its risks. View on euronews ...
    11/14/2024 - 9:50 pm | View Link
  • New Alzheimer’s research reveals ‘quiet’ phase of the disease, before symptoms appear
    New details have emerged about how Alzheimer’s disease affects the brain. Researchers led by the Allen Institute for Brain Science in Seattle and University of Washington Medicine have ...
    10/18/2024 - 8:09 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More U.s. News